Transaortic aortic valve implantation (TAo-AVI) through the ascending aorta is a novel technique and is used as an alternative in patients with poor femoral access. Although early results have been promising, no midterm data have been published yet. To determine whether this approach is an acceptable treatment option, we analyzed the first 100 cases performed at our institution with a follow-up to 3 years.
Methods
Between July 2011 and January 2015, a total of 100 patients with high-risk or inoperable aortic valve stenosis were treated with TAo-AVI. Preoperative patient data were collected and analyzed retrospectively. All surviving patients were seen for clinical and echocardiographic examination for follow-up.
Results
Median follow-up was 15 months. Device success was accomplished in 94 patients (94%). There were no access site complications. The 30-day mortality rate was 9%. Stroke occurred in a total of six patients (6%). Survival at 1-, 2-, and 3 years was 75%, 62%, and 58%, respectively.
Conclusions
Our results show that TAo-AVI is a promising alternative to transapical implantation for treating severe inoperable aortic valve stenosis.
LeonM.B., SmithC.R., MackM.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med.2010; 363: 1597–1607.
2.
MakkarR.R., FontanaG.P., JilaihawiH.Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med.2012; 366: 1696–1704.
3.
AdamsD.H., PopmaJ.J., ReardonM.J.Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med.2014; 370: 1790–1798.
4.
ThomasM., SchymikG., WaltherT.One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation.2011; 124: 425–433.
BapatV., KhawajaM.Z., AttiaR.Transaortic transcatheter aortic valve implantation using Edwards Sapien valve: a novel approach. Catheter Cardiovasc Interv.2012; 79: 733–740.
7.
EtienneP.Y., PapadatosS., ElK.E., PietersD., PriceJ., GlineurD.Transaortic transcatheter aortic valve implantation with the Edwards SAPIEN valve: feasibility, technical considerations, and clinical advantages. Ann Thorac Surg.2011; 92: 746–748.
8.
ClarkeA., WiemersP., PoonK.K.Early experience of transaortic TAVI—the future of surgical TAVI?Heart Lung Circ.2013; 22: 265–269.
9.
HayashidaK., RomanoM., LefevreT.The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience. Eur J Cardiothorac Surg.2013; 44: 692–700.
10.
LardizabalJ.A., O'NeillB.P., DesaiH.V.The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol.2013; 61: 2341–2345.
11.
YongZ.Y., WiegerinckE.M., Boerlage-van DijkK.Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation. Circ Cardiovasc Interv.2012; 5: 415–423.
12.
RibeiroH.B., DahouA., UrenaM.Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement. Ann Thorac Surg.2015; 99: 2001–2009.
13.
BonacchiM., PriftiE., GiuntiG., FratiG., SaniG.Does ministernotomy improve postoperative outcome in aortic valve operation? A prospective randomized study. Ann Thorac Surg.2002; 73: 460–465.
AmraneH., PortaF., van BovenA.J.Transcatheter aortic valve implantation using a direct aortic approach: a single-centre heart team experience. Interact Cardiovasc Thorac Surg.2014; 19: 777–781.
16.
LardizabalJ.A., MaconC.J., O'NeillB.P.Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement. Catheter Cardiovasc Interv.2015; 85: 1226–1230.
17.
KappeteinA.P., HeadS.J., GenereuxP.Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol.2012; 60: 1438–1454.
18.
RahnavardiM., SantibanezJ., SianK., YanT.D.A systematic review of transapical aortic valve implantation. Ann Cardiothorac Surg.2012; 1: 116–128.
19.
LiX., KongM., JiangD., DongA.Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg.2013; 8: 168.
20.
WaltherT., KempfertJ., RastanA.Transapical aortic valve implantation at 3 years. J Thorac Cardiovasc Surg.2012; 143: 326–331.
21.
YeJ., CheungA., LichtensteinS.V.Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg.2010; 139: 1107–1113.
22.
WendlerO., WaltherT., SchroefelH.Transapical aortic valve implantation: mid-term outcome from the SOURCE registry. Eur J Cardiothorac Surg.2013; 43: 505–511.
23.
BlackstoneE.H., SuriR.M., RajeswaranJ.Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation.2015; 131: 1989–2000.
24.
HolmesD.R.Jr., NishimuraR.A., GroverF.L.Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. J Am Coll Cardiol.2015; 66: 2813–2823.
25.
BinderR.K., Rodés-CabauJ., WoodD.A.Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv.2013; 6: 293–300.
26.
BramlageP., RomanoM., BonarosN.Transaortic transcatheter aortic valve implantation - rationale and design of the multicenter, multinational prospective ROUTE registry. BMC Cardiovasc Disord.2014; 14: 152.
